M4MM

Connecticut Lawmakers Expand Psychedelics Access

HARTFORD – Connecticut's Joint Committee on Public Health approved a bill that broadens the state's pilot program for psychedelic-assisted therapy, opening it to adults beyond just veterans and first responders. The measure, Senate Bill 191, ...

RYTHM Reports Q4 and FY 2025 Financial Results

ROLLING MEADOWS – RYTHM Inc. delivered a significant revenue leap in 2025, fueled by licensing deals in the fast-growing low-dose Cannabis alternatives market. Full-year sales hit $17.3 million, yet the company posted a $33.3 million ...

Atai Gains Nasdaq Biotechnology Index Spot

NEW YORK – AtaiBeckley N.V., the clinical-stage biopharmaceutical firm born from the November merger of atai Life Sciences and Beckley Psytech, has secured a place in the Nasdaq Biotechnology Index (NBI), a move that underscores ...

Connecticut Lawmakers Expand Psychedelics Access

HARTFORD – Connecticut's Joint Committee on Public Health approved a bill that broadens the state's pilot program for psychedelic-assisted therapy, opening it to adults beyond just veterans and first responders. The measure, Senate Bill 191, ...

RYTHM Reports Q4 and FY 2025 Financial Results

ROLLING MEADOWS – RYTHM Inc. delivered a significant revenue leap in 2025, fueled by licensing deals in the fast-growing low-dose Cannabis alternatives market. Full-year sales hit $17.3 million, yet the company posted a $33.3 million ...

Organigram Announces Investment in Open Book Extracts

NEW YORK- Organigram Holdings, a Canadian cannabis company, announced a $2 million investment in North Carolina-based Open Book Extracts. This move signifies Organigram's entry into the U.S. cannabis market, facilitated by an investment from British ...

Algernon Pharmaceuticals Advances Research Program

LOS ANGELES – In a significant move that underscores its commitment to innovative medical research, Algernon Pharmaceuticals Inc. announced its decision to prioritize its AP-188 ("N,N-Dimethyltryptamine" or "DMT") stroke research program. This announcement follows the ...

Glass House Brands Report Revenue and Profits

LOS ANGELES- In a notable financial turnaround, Glass House Brands, a California-based cannabis producer and retailer, reported significant growth in its fourth-quarter earnings, leading to a record revenue of $160.8 million for the fiscal year ...

ICER Raises Concerns Over MDMA-Assisted Psychotherapy for PTSD

LOS ANGELES- The Institute for Clinical and Economic Review (ICER) has recently highlighted significant concerns regarding the clinical evidence behind MDMA-assisted psychotherapy (MDMA-AP) for post-traumatic stress disorder (PTSD), according to a draft evidence report. This ...

Psilera Strengthens Board with Neuroscience

TAMPA –Psilera, a biotechnology company specializing in novel treatments for complex neurological disorders, has announced the addition of Dr. Magali Haas, M.D., Ph.D., to its Board of Directors. Dr. Haas, with an illustrious career spanning ...

Subscribe To Our Newsletter